Documents A Regulatory Perspective on Design and Analysis of Combination Drug Trial* H.M. James Hung Division....

Slide 1A Regulatory Perspective on Design and Analysis of Combination Drug Trial* H.M. James Hung Division of Biometrics I, Office of Biostatistics OPaSS, CDER, FDA Presented…